Kane Biotech and ProgenaCare Global Launch Newly Rebranded revyve™ Antimicrobial Wound Gel at Advanced Wound Care Fall Forum Nov 2, 2023
Kane Biotech Announces Closing of Fully Subscribed Private Placement Offering and Amendments to its Credit Facility Sep 12, 2023
Kane Biotech to Release Second Quarter 2023 Financial Results on Aug 29, 2023 – Conference Call to Follow Aug 22, 2023
Kane Biotech Announces Private Placement Offering and Proposed Amendments to its Credit Facility Aug 3, 2023
